Economic Issues in Heart Failure in the United States.
J Card Fail
; 28(3): 453-466, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1850744
ABSTRACT
The cost of heart failure care is high owing to the cost of hospitalization and chronic treatments. Heart failure treatments vary in their benefit and cost. The cost effectiveness of therapies can be determined by comparing the cost of treatment required to obtain a certain benefit, often defined as an increase in 1 year of life. This review was sponsored by the Heart Failure Society of America and describes the growing economic burden of heart failure for patients and the health care system in the United States. It also provides a summary of the cost effectiveness of drugs, devices, diagnostic tests, hospital care, and transitions of care for patients with heart failure. Many medications that are no longer under patent are inexpensive and highly cost-effective. These include angiotensin-converting enzyme inhibitors, beta-blockers and mineralocorticoid receptor antagonists. In contrast, more recently developed medications and devices, vary in cost effectiveness, and often have high out-of-pocket costs for patients.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Insuficiencia Cardíaca
Tipo de estudio:
Estudios diagnósticos
/
Estudio observacional
Tópicos:
Covid persistente
Límite:
Humanos
País/Región como asunto:
America del Norte
Idioma:
Inglés
Revista:
J Card Fail
Asunto de la revista:
Cardiología
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS